BioAtla公司宣布,将与Gatc Health共同和人工智能企业Inversagen展开合作,致力于推进Cab衰老细胞清除疗法的研发进程。此次合作旨在整合多方技术优势,加速创新疗法开发。
BioAtla公司宣布,将与Gatc Health共同和人工智能企业Inversagen展开合作,致力于推进Cab衰老细胞清除疗法的研发进程。此次合作旨在整合多方技术优势,加速创新疗法开发。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.